MARC record from Internet Archive

LEADER: 07656cam 22015494i 4500
001 ocm40675057
003 OCoLC
005 20200626091320.0
008 990114s1999 ilu b 000 0 eng
010 $a 99012162
040 $aDLC$beng$erda$cDLC$dUKM$dC#P$dNLM$dBAKER$dNLGGC$dBTCTA$dLVB$dYDXCP$dIG#$dUBC$dHEBIS$dEXW$dZWZ$dBDX$dDEBBG$dDEBSZ$dOCLCQ$dOCLCO$dOCLCA$dOCLCQ$dCTB$dOCLCA$dDHA$dOCLCA$dOCLCQ$dOCLCF$dGYG$dRCC$dOCLCA$dCEF$dTKN$dMRM$dHCO$dCRU$dFQG$dOCLCQ$dPAU$dOCLCO$dCPO$dCNO$dSNN$dBUB$dINT$dQE2$dOCLCQ$dBGU$dOCLCO$dOCLCQ$dOCLCO$dUKMGB$dOCLCQ$dOCLCA$dUKUOY$dSXQ$dOCLCO$dOCLCQ$dOCLCO$dOCLCQ$dUKBTH$dOCLCA$dAOW$dL2U$dOCLCO$dOCLCQ$dOCLCA
015 $aGB99W4249$2bnb
015 $aGBA060119$2bnb
016 7 $a100896426$2DNLM
016 7 $a007139415$2Uk
016 7 $a007366769$2Uk
019 $a45315574$a1022652822
020 $a0226701506$q(alk. paper)
020 $a9780226701509$q(alk. paper)
024 3 $a9780226701509
035 $a(OCoLC)40675057$z(OCoLC)45315574$z(OCoLC)1022652822
042 $apcc
043 $ae-fr---$an-us---
050 00 $aQH431$b.R236 1999
060 00 $a1999 H-195
060 10 $aQH 431$bR116f 1999
080 $a575.21
082 00 $a611/.01816$221
084 $a02.10$2bcl
084 $aMS 6000$2rvk
100 1 $aRabinow, Paul,$eauthor.
245 10 $aFrench DNA :$btrouble in purgatory /$cPaul Rabinow.
264 1 $aChicago, IL :$bUniversity of Chicago Press,$c1999.
300 $avii, 201 pages ;$c22 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references (pages 183-199).
505 00 $tLife as We Know It --$tGenomic Assemblages --$tField Notes: The CEPH after Its Victory --$tLife: Dignity and Value --$tMillennium Comes to Paris --$tNormalization --$tEpilogue: The Anthropological Contemporary.
520 1 $a"In 1993, an American biotechnology company, Millennium Pharmaceuticals, and France's premier genetics lab, the Centre d'Etude du Polymorphisme Humaine (CEPH), developed plans for a collaborative effort to discover diabetes genes. The two companies had agreed that the CEPH would supply Millennium with a store of genetic material collected from a large number of French families, and Millennium would supply funding and expertise in new technologies to accelerate the identification of the genes, terms that the French government had approved. But in early 1994, just as the collaboration was to begin, the French government abruptly called a halt. The government insisted that under no circumstances could the CEPH be permitted to give the Americans that most precious of all substances - never before named in such a manner - French DNA." "French DNA is about international competition, the future of human health, ferocious financial conflict and the intersection of culture and science - the place where, finally DNA became French."--Jacket.
583 1 $aLegacy$c2018$5UoY
610 20 $aCentre d'étude du polymorphisme humain.
610 20 $aMillennium Pharmaceuticals, Inc.
650 0 $aHuman genetics$xGovernment policy$zFrance.
650 0 $aNon-insulin-dependent diabetes$xResearch$zUnited States.
650 0 $aNon-insulin-dependent diabetes$xResearch$zFrance.
650 0 $aHuman genome.
650 0 $aHuman gene mapping$zFrance.
650 0 $aBiotechnology industries$zUnited States.
610 22 $aCentre d'étude du polymorphisme humain
610 22 $aMillennium Pharmaceuticals, Inc
650 12 $aGenetics.
650 22 $aBiotechnology.
650 22 $aChromosome Mapping.
650 22 $aDiabetes Mellitus, Type 2$xgenetics.
650 22 $aGenome, Human.
650 22 $aInternational Cooperation.
650 22 $aResearch.
651 2 $aFrance.
651 2 $aUnited States.
610 26 $aCentre d'étude du polymorphisme humain.
610 26 $aMillennium Pharmaceuticals, Inc.
650 6 $aGénétique humaine$xPolitique gouvernementale$zFrance.
650 6 $aDiabète non insulinodépendant$xRecherche$zÉtats-Unis.
650 6 $aDiabète non insulinodépendant$xRecherche$zFrance.
650 6 $aGénome humain.
650 6 $aCartes chromosomiques humaines$zFrance.
650 6 $aBio-industries$zÉtats-Unis.
650 7 $a02.10 science and society.$0(NL-LeOCL)07759245X$2bcl
610 27 $aCentre d'étude du polymorphisme humain.$2fast$0(OCoLC)fst00744549
610 27 $aMillennium Pharmaceuticals, Inc.$2fast$0(OCoLC)fst00744550
650 7 $aBiotechnology industries.$2fast$0(OCoLC)fst00832791
650 7 $aHuman gene mapping.$2fast$0(OCoLC)fst00963066
650 7 $aHuman genetics$xGovernment policy.$2fast$0(OCoLC)fst00963079
650 7 $aHuman genome.$2fast$0(OCoLC)fst00963101
651 7 $aFrance.$2fast$0(OCoLC)fst01204289
651 7 $aUnited States.$2fast$0(OCoLC)fst01204155
650 7 $aCartographie chromosomique$xFrance.$2fmesh
650 7 $aCartographie chromosomique$xÉtats Unis d'Amérique.$2fmesh
650 7 $aDiabète de type 2$xgénétique$xFrance.$2fmesh
650 7 $aDiabète de type 2$xgénétique$xÉtats Unis d'Amérique.$2fmesh
650 7 $aGénome humain$xFrance.$2fmesh
650 7 $aGénome humain$xÉtats Unis d'Amérique.$2fmesh
610 27 $aCentre d'Etude du Polymorphisme Humain$2gnd
610 27 $aMillennium Pharmaceuticals Inc.$2gnd
610 27 $aUmschulungswerkstätten für Siedler und Auswanderer$gBitterfeld$2gnd
650 7 $aDiabetes mellitus$2gnd
650 7 $aGenomprojekt$2gnd
650 7 $aGentherapie$2gnd
650 7 $aInternationale Kooperation$2gnd
651 7 $aFrankreich$2gnd
650 17 $aBiomedisch onderzoek.$2gtt
650 17 $aGenetica.$2gtt
650 17 $aDiabetes mellitus type 2.$2gtt
650 17 $aSamenwerking.$2gtt
650 17 $aWetenschapsbeleid.$2gtt
650 17 $aPolitieke aspecten.$2gtt
610 27 $aFondation Jean Dausset-CEPH.$2ram
650 7 $aGénétique humaine$xPolitique publique$zFrance.$2ram
650 7 $aGénétique humaine$xPolitique publique$zÉtats-Unis.$2ram
650 7 $aDiabète$xRecherche$zFrance.$2ram
650 7 $aDiabète$xRecherche$zÉtats-Unis.$2ram
650 7 $aGénome humain.$2ram
650 7 $aChromosomes humains$xCartes$zFrance.$2ram
650 7 $aBio-industries.$2ram
651 7 $aFrankreich.$2swd
856 41 $3Table of contents$uhttp://catdir.loc.gov/catdir/toc/uchi052/99012162.html
856 42 $3Contributor biographical information$uhttp://catdir.loc.gov/catdir/bios/uchi051/99012162.html
856 42 $3Publisher description$uhttp://catdir.loc.gov/catdir/description/uchi052/99012162.html
856 42 $uhttp://library.ccsu.edu/help/spcoll/oconnell/French%20DNA.pdf$zO'Connell Notes (PDF)
856 42 $uhttp://library.ccsu.edu/help/spcoll/oconnell/index.htm$zEntire Brian O'Connell Collection
938 $aBaker & Taylor$bBKTY$c25.00$d25.00$i0226701506$n0003270662$sactive
938 $aBrodart$bBROD$n53903722$c$25.00
938 $aBaker and Taylor$bBTCP$n99012162
938 $aIngram$bINGR$n9780226701509
938 $aYBP Library Services$bYANK$n1586050
029 1 $aAU@$b000014471852
029 1 $aDEBBG$bBV012921704
029 1 $aDEBSZ$b081656165
029 1 $aGEBAY$b6104221
029 1 $aHEBIS$b123714869
029 1 $aHR0$b0226701506
029 1 $aIG#$b9780226701509
029 1 $aNLGGC$b180326449
029 1 $aNLM$b100896426
029 1 $aNZ1$b2489937
029 1 $aUKMGB$b007139415
029 1 $aUKMGB$b007366769
029 1 $aUNITY$b018946526
029 1 $aYDXCP$b1586050
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 447 OTHER HOLDINGS